ASX healthcare shares could be next to be hit by the digital disruption

You might think ASX healthcare shares would be among the most insulated from the digital disruption, but that view doesn't gel with all experts.

You might think ASX healthcare shares would be among the most insulated from the digital disruption, but that view doesn't gel with all experts.

In fact, some are predicting that the healthcare sector could be next to be shaken by the digital and online revolution, reported the Australian Financial Review.

The news may worry many investors holding ASX healthcare shares. They only need to look at the media and retail sectors to see how significant the impact of this may be.

ASX healthcare digital disruption woman has medical consultation appointment video video call with her doctor.

Image Source: Getty Images

ASX medical shares and the digital disruption

The idea that some medical services could be heading online and away from brick-and-mortar outlets isn't that preposterous. COVID-19 proved the benefits of telemedicine.

But before you equate the Myer Holdings Ltd (ASX: MYR) share price with the Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) share price, Sonic Healthcare Limited (ASX: SHL) share price or Healius Ltd (ASX: HLS) share price, consider these points.

The experts quoted in the AFR article spoke more about data collection than visits to doctors or hospitals.

More about data than visitation

The idea is that the pooling of non-identifiable patient data could help medical practitioners and patients make more informed decisions.

Such stats might be useful for Monash IVF Group Ltd (ASX: MVF) for instance where statistics could help improve the chances of a successful treatment.

But change never comes easy. This is especially so for the medical fraternity as these professionals are trained to avoid risk and to stick to tried and proven methods.

What's needed to drive the digital change

The factor that could counteract the resistance for change is cost savings. This is one of the largest expenditure items for federal and state governments.

This provides a big incentive to embrace digital technologies, especially during these times when government budgets have blown out due to the pandemic.

If consumers believe that the digital disruption will also help them cut their bills, including health insurance bills, and speed up treatments, they could also be a powerful push factor.

Needless to say, the Medibank Private Ltd (ASX: MPL) share price and NIB Holdings Limited (ASX: NHF) share price would welcome anything that bolsters their margins.

Real risk to earnings from digital disruption

On the other hand, if digital medicine does lower costs, medical facility owners could feel the squeeze in parts of their operations.

Even if margins stay constant on a percentage of sales basis, profits will drop as the top-line drops.

Further, the digital revolution will provide opportunities for new rivals to challenge and beat the incumbents. We don't need to list any examples here.

But there's no need for ASX investors to panic. Even if there is a greater acceptance of telemedicine, changes come slowly. It took years for digital alternatives to dislodge newspapers and brick and mortar retailers.

This gives the sector precious reaction time to pivot and adapt.

Motley Fool contributor Brendon Lau owns shares of Sonic Healthcare Limited. Connect with me on Twitter @brenlau.

The Motley Fool Australia has recommended NIB Holdings Limited, Ramsay Health Care Limited, and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Falling pills in a blue background.
Healthcare Shares

Mayne shares are up 80% on takeover news, but there's still money to be made

Major shareholders are backing the deal in.

Read more »

Male and female scientists analysing data on a computer.
Healthcare Shares

Why I'd buy this ASX biotechnology company over CSL

The potential for research-driven growth could be large.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Neuren Pharmaceuticals shares just hit a 12-month high. There could be more good news to come

This week's sales figures were impressive.

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

Do I still rate CSL shares as a buy after rising 120% in four months?

Let's see if it is too late to buy this biotech giant's shares.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Healthcare Shares

CSL shares push past $200: Is $250 next?

How much further can the CSL share price rally go?

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

ResMed or Cochlear: Which ASX healthcare share would I buy today?

I like both businesses for the long term, but their recent financial performances have given me something to think about.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Could Telix Pharmaceuticals shares double in value over the next 12 months?

Find out if the ASX biotech stock is a buy, sell, or hold now.

Read more »